TDP1 and neoplasm: Their subsequent synthesized hydrazinothiazole usnic acid derivative (R,E)-2-acetyl-6-(2-(2-(4-bromobenzyliden)hydrazinyl)thiazol-4-yl)-3,7,9-trihydroxy-8, 9b-dimethyldibenzo[b,d]furan-1(9bH)-one is an effective Tdp1 catalytic inhibitor that increased topotecan toxicity in a Lewis lung carcinoma cell model and was the first potential Tdp1 inhibitor to show, in combination with topotecan, an anti-tumor and anti-metastatic effect in a mouse model of Lewis Lung Carcinoma[67].